Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Therapy-related myelodysplastic syndromes-specific risk stratification: Are we putting the cart before the horse?

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 09/11/2017 - 9:05am.

  2. Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes.

    ... Transfusion dependence (TD) among myelodysplastic syndromes (MDS) patients negatively impacts survival and health-related ...

    Research Article last updated 05/22/2017 - 11:01am.

  3. Promising trial results for lower-risk MDS drug

    ... for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open- ...

    Article last updated 09/07/2017 - 11:08am.

  4. Foundation Update - June 2016

    ... understanding and treatment of aplastic anemia , myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH). ...

    Article last updated 10/09/2017 - 2:54pm.

  5. Foundation Update - June 2017

    ... understanding and treatment of aplastic anemia , myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH). The ...

    Article last updated 10/09/2017 - 2:42pm.

  6. Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

    ... Current prognostic models for myelodysplastic syndromes (MDS), including the Revised International Prognostic Scoring ...

    Research Article last updated 05/02/2017 - 10:37am.

  7. Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

    ... MAC with RIC in patients with acute myeloid leukemia or myelodysplastic syndromes . Patients and Methods Patients age 18 to 65 years with HCT ...

    Research Article last updated 05/02/2017 - 10:29am.

  8. An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes

    ... Myelodysplastic syndromes (MDSs) are characterized by ineffective hematopoiesis and ...

    Research Article last updated 05/02/2017 - 10:33am.

  9. Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failure

    ... Myelodysplastic syndromes (MDS) are clonal stem cell disorders marked by bone marrow ...

    Research Article last updated 04/14/2017 - 8:47am.

  10. Infectious complications in patients with myelodysplastic syndromes: a review of the literature with emphasis on patients treated with 5-azacitidine

    ... Myelodysplastic syndromes (MDS) are oligo-clonal diseases of the hematopoietic stem cell ...

    Research Article last updated 04/14/2017 - 10:41am.